Effect of atorvastatin on chronic periodontitis: a randomized pilot study

Area of Science:

• Periodontology
• Pharmacology
• Biochemistry

Background:

• Chronic periodontitis is a prevalent inflammatory condition leading to alveolar bone loss and tooth mobility.
• Statins, like atorvastatin (ATV), are primarily used for cholesterol management but may possess anti-inflammatory and bone-protective properties.

Purpose of the Study:

• To investigate the efficacy of atorvastatin (ATV) in preventing bone loss in patients with chronic periodontitis.
• To assess the impact of ATV on clinical and radiographic parameters, as well as bone turnover markers in periodontitis subjects.

Main Methods:

• A controlled, double-blind study involving 38 chronic periodontitis patients randomized to receive either 20 mg of atorvastatin (ATV) or a placebo daily for 3 months.
• Both groups received periodontal mechanical treatment at baseline.
• Clinical, radiographic, and bone turnover markers were evaluated at baseline and after 3 months.

Main Results:

• Atorvastatin (ATV) treatment significantly improved cholesterol and low-density lipoprotein levels compared to placebo.
• Patients receiving ATV demonstrated significant reductions in dental mobility and alveolar bone loss (distance from crestal bone to cemento-enamel junction).
• Periodontal disease conditions improved in both ATV and placebo groups, but ATV showed statistically significant benefits in key parameters.

Conclusions:

• Atorvastatin (ATV) may offer beneficial effects in mitigating alveolar bone loss associated with periodontal disease.
• The findings suggest that atorvastatin (ATV) could be a potential adjunctive therapy for managing tooth mobility in periodontitis patients.